Leveraging Europe's Expertise to accelerate Cell Therapy for Type 1 Diabetes

T1D (Type 1 Diabetes) is an autoimmune disease that destroys insulin-producing pancreatic beta-cells, leading to lifelong insulin dependence. Despite advances in technology, achieving stable blood glucose levels remains challenging, which increases the risk of severe complications, and this in turn impacts negatively on daily life, work productivity, and mental health, and contributes to stress, anxiety, and depression. Beta-cell replacement therapy offers a promising path towards a functional cure, but critical challenges must be addressed, including the need for renewable cell sources, optimised [...]